Highlights from the BIO CEO and Investor Conference Panel: “Market Outlook: Assessing Readiness for the Next IPO Window”

Centri’s Ryan Starkes, Partner and Life Sciences Practice Leader, recently spoke on the “Market Outlook: Assessing Readiness for the Next IPO Window” panel at the Biotechnology Innovation Organization (BIO) CEO and Investor Conference in New York City. Ryan and the other panelists shared their thoughts on the biotech IPO market outlook. 

Some highlights from the session include:

  • Positive Outlook – The panelists predict a strong outlook for biotech companies looking to go public.  After a few slow years, they anticipate a healthier pace of IPOs.
  • Macroeconomic Factors – Between the Federal Reserve’s indications of lower interest rates and investors rich with “dry powder” due to earnings from mergers or staying out of the market for a couple of years, robust M&A activity is driving enthusiasm for the biotech market.
  • Preparation is Key – Companies should prepare well in advance for IPOs.  Ryan shared, “Get ahead of it now, and you’ll be ready when the time comes and you can take advantage of it. You can present yourself in a much better light.”

Following the preparation theme, Ryan urged companies to “Let the science dictate the value. Don’t let financial statements and things of that nature get in the way.” Companies should focus on their story, the value of their research, and the milestones achieved. When they are diligent in keeping their financial statements and related valuations and processes in order, they won’t be held back in completing a transaction.

How Centri Can Help

Our seasoned team of experts in the Life Sciences industry, SEC Financial Reporting & Compliance, IPO & Capital Markets Readiness, Valuation, and M&A Advisory practices work together to provide guidance at every stage of your company’s lifecycle. Contact us to learn how we can help your company position itself for growth.

About Centri Business Consulting, LLC

Centri Business Consulting provides the highest quality advisory consulting services to its clients by being reliable and responsive to their needs. Centri provides companies with the expertise they need to meet their reporting demands. Centri specializes in financial reportinginternal controlstechnical accounting researchvaluationmergers & acquisitions, and tax, CFO and HR advisory services for companies of various sizes and industries. From complex technical accounting transactions to monthly financial reporting, our professionals can offer any organization the specialized expertise and multilayered skillsets to ensure the project is completed timely and accurately.

Eight Penn Center
1628 JFK Boulevard
Suite 500
Philadelphia, PA 19103
New York City
530 Seventh Avenue
Suite 2201
New York, NY 10018
4509 Creedmoor Rd
Suite 206
Raleigh, NC 27612
615 Channelside Drive
Suite 207
Tampa, FL 33602
1175 Peachtree Street NE
Suite 1000
Atlanta, GA 30361
50 Milk Street
18th Floor
Boston, MA 02109
Tysons Corner
1775 Tysons Blvd
Suite 4131
McLean, VA 22102
One Tabor Center
1200 17th St.
Floor 26
Denver, CO 80202
Centri Everywhere


Accounting for and Disclosure of Crypto Assets – Observations from Adopting ASC 350-60

Companies that have not yet adopted ASC 350-60, Accounting for and Disclosure...

Read More


Will Your 409A Valuation Report Hold Up to the IRS Challenge? 3 Key Things to Look For

As businesses navigate the complexities of valuation, assessing the robustness of 409A...

Read More


Segment Disclosure Updates – Single Reportable Segment

In November 2023, the Financial Accounting Standards Board (FASB) issued an Accounting...

Read More

Related Services